Table 1 Blood culture findings of patients investigated for sepsis at four different hospitals in Ethiopia
From: Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals
Sociodemographic data | Blood culture result | |||||
|---|---|---|---|---|---|---|
n (%) | Bacterial growth n (%) | No bacterial growth n (%) | Possibly contaminants n (%) | Yeast cells n (%) | ||
Hospitals | TASH | 501 (35.4) | 123 (24.6) | 335 (66.9) | 43 (8.6) | 0(0.0) |
Y12HMC | 298 (21) | 55 (18.5) | 191 (64.1) | 51 (17.1) | 1 (0.3) | |
DRH | 301 (21.3) | 115 (38.2) | 142 (47.2) | 44 (14.6) | 0 (0.0) | |
HUCSH | 316 (22.3) | 92 (29.1) | 173 (54.7) | 48 (15.2) | 3 (0.9) | |
Gender | Male | 783 (55.3) | 210 (26.8) | 462 (59) | 108 (13.8) | 3 (0.4) |
Female | 633 (44.7) | 175 (27.6) | 379 (59.9) | 78 (12.3) | 1 (0.2) | |
Age category | < 29 days | 586 (41.4) | 230 (39.2) | 258 (44) | 94 (16) | 4 (0.7) |
≥ 30 days to ≤ 1 year | 256 (18.1) | 45 (17.6) | 182 (71.1) | 29 (11.3) | 0 (0.0) | |
1–5 years | 135 (9.5) | 33 (24.4) | 84 (62.2) | 18 (13.3) | 0 (0.0) | |
5–18 years | 158 (11.2) | 26 (16.5) | 111 (70.3) | 21 (13.3) | 0 (0.0) | |
≥ 18 years | 281 (19.8) | 51 (18.1) | 206 (73.3) | 24 (8.5) | 0 (0.0) | |
Ward | EOPD | 104 (7.3) | 15 (14.4) | 79(76) | 10 (9.6) | 0 (0.0) |
ICU | 38 (2.7) | 8 (21.1) | 28 (73.7) | 2 (5.3) | 0 (0.0) | |
Medical ward | 148 (10.5) | 24 (16.2) | 111 (75) | 13 (8.8) | 0 (0.0) | |
NICU | 596 (42.1) | 232 (39.9) | 265 (45.5) | 95 (15.9) | 4 (0.7) | |
Pediatrics | 497 (35.1) | 94 (18.9) | 342 (68.8) | 61 (12.3) | 0 (0.0) | |
Surgical ward | 33 (2.3) | 12 (36.4) | 16 (48.5) | 5 (15.2) | 0 (0.0) | |
Referral patient | Yes | 722 (51) | 190 (26.3) | 444 (61.5) | 87 (12) | 1 (0.1) |
No | 694 (49) | 195 (28.1) | 397 (57.2) | 99 (14.3) | 3 (0.4) | |
Previous admission | Yes | 299 (21.1) | 69 (23.1) | 197 (65.9) | 32 (10.7) | 1 (0.3) |
No | 1117 (78.9) | 316 (28.3) | 644 (57.7) | 154 (13.8) | 3 (0.3) | |
Hospital stay duration | 1 week | 828 (58.5) | 244 (29.5) | 464 (56) | 117 (14.1) | 3 (0.4) |
2 weeks | 222 (15.7) | 52 (23.4) | 141 (63.5) | 28 (12.6) | 1 (0.5) | |
3 weeks | 146 (10.3) | 35 (24) | 97 (66.4) | 14 (9.6) | 0 (0.0) | |
4 weeks and above | 220 (15.5) | 54 (24.5) | 139 (63.2) | 27 (12.3) | 0 (0.0) | |
Underlying diseases | Yes | 665 (47) | 159 (23.9) | 433(65.1) | 71(10.7) | 2 (0.3) |
No | 751 (53) | 226 (30.1) | 408(54.3) | 115(15.3) | 2 (0.3) | |
Previous antibiotic treatment before recruitment to the study | Yes | 440 (31.1) | 121 (27.5) | 269(61.1) | 48(10.9) | 2 (0.5) |
No | 976 (68.9) | 264 (27) | 572(58.6) | 138(14.1) | 2 (0.2) | |
Fever | Up to 3 days | 687 (64.4) | 210 (30.6) | 380 (55.3) | 95 (13.8) | 2 (0.3) |
4–6 days | 207 (19.4) | 48 (23.2) | 144 (69.6) | 15 (7.2) | 0 (0.0) | |
7 days and above | 173 (16.2) | 31 (17.9) | 122 (70.5) | 20 (11.6) | 00 (0.0) | |
No | 349 (24.6) | 96 (27.5) | 195 (55.9) | 56 (16.0) | 2 (0.6) | |
Total | 1416 (100) | 385 (27.2) | 841 (59.4) | 186 (13.1) | 4 (0.3) | |
BMI class | Underweight | 749 (72.2) | 173 (23.1) | 472 (63) | 102 (13.6) | 2 (0.3) |
Normal | 233 (22.4) | 47 (20.2) | 163 (70) | 23 (9.9) | 0 (0.0) | |
Overweight | 26 (2.5) | 7 (26.9) | 18 (69.2) | 1 (3.8) | 0 (0.0) | |
Obese | 30 (2.9) | 11 (36.7) | 17 (56.7) | 2 (6.7) | 0 (0.0) | |
Total for BMI | 1038 (100) | 238 (22.9) | 670 (64.5) | 128 (12.3) | 2 (0.2) | |